Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Arylpiperazines as serotonin reuptake inhibitors and 5-HT1D&agr; antagonists

Arylpiperazines as serotonin reuptake inhibitors and 5-HT1D&agr; antagonists

US Patent 6342498 · Granted Jan 29, 2002

Estimated economic value: $276,544,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic heterocycles as FGFR inhibitors2024
Bicyclic heterocycles as FGFR inhibitors2023
Triazolopyridine compounds2016
Triazolopyridine compounds2015
Inhibitor(s) of transporters or uptake of monoaminergic neurotransmitters2014
Pyridinoylpiperidines as 5-HT1F agonists2014
Heterocyclic oxime compounds2013
Heterocyclic hydrazone compounds2013
Heterocyclic oxime compounds2013
(Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl a2009
Pyridinoylpiperidines as 5-HT1F agonists2008
Inhibitor of monoamine uptake2008